SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-24-000398
Filing Date
2024-01-22
Accepted
2024-01-22 09:33:58
Documents
4
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20240301xpre14a.htm PRE 14A 217397
2 GRAPHIC tmb-20240301xpre14a_a001.jpg GRAPHIC 13092
3 GRAPHIC tmb-20240301xpre14a_bg001.jpg GRAPHIC 110071
4 GRAPHIC tmb-20240301xpre14a_bg002.jpg GRAPHIC 121037
  Complete submission text file 0001558370-24-000398.txt   555283
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39811 | Film No.: 24547288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)